SL
SGMT icon

Siren LLC’s Sagimet Biosciences SGMT Stock Holding History

Siren LLC’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-724,771
Closed -$4.29M – 121
2025
Q4 		$4.29M Hold
724,771
– – 0.13% 85
2025
Q3 		$4.97M Hold
724,771
– – 0.19% 66
2025
Q2 		$5.52M Hold
724,771
– – 0.29% 60
2025
Q1 		$2.36M Hold
724,771
– – 0.13% 78
2024
Q4 		$3.26M Hold
724,771
– – 0.14% 79
2024
Q3 		$2.01M Buy
+724,771
New +$2.23M 0.1% 83

Other funds holding SGMT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Siren LLC's SGMT Position: Q1 2026 in Review

Siren LLC sold out of Sagimet Biosciences (SGMT) in Q1 2026, closing a stake of 724,771 shares — an estimated $4.29M sold.

Siren LLC first reported a position in SGMT in Q3 2024 and held it in 6 quarters. The position peaked at $5.52M in Q2 2025. 88 funds tracked by Wall St. Rank hold SGMT as of Q1 2026.

  • Siren LLC reported no remaining Sagimet Biosciences position as of Q1 2026 after selling out during the quarter.
  • Siren LLC sold 724,771 Sagimet Biosciences shares in Q1 2026, an estimated $4.29M.
  • Siren LLC first reported a position in Sagimet Biosciences in Q3 2024 and held it in 6 quarters.
  • Siren LLC's Sagimet Biosciences position peaked at $5.52M in Q2 2025.
  • 88 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q1 2026.

Based on Siren LLC's 13F filing for Q1 2026, filed 14 May 2026.